Response to Hepatitis B Vaccine in HIV‐1–Positive Subjects Who Test Positive for Isolated Antibody to Hepatitis B Core Antigen: Implications for Hepatitis B Vaccine Strategies
Author(s) -
Rajesh T. Gandhi,
Alysse G. Wurcel,
Hang Lee,
Barbara McGovern,
Janet Shopis,
Meghan Geary,
Rohini Sivamurthy,
Paul E. Sax,
Chinweike Ukomadu
Publication year - 2005
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/429302
Subject(s) - virology , medicine , antibody , immunology , antigen , hepatitis b , hepatitis b vaccine , hepatitis , human immunodeficiency virus (hiv) , hepatitis b virus , virus , hbsag
Whether human immunodeficiency virus type 1 (HIV-1)-positive subjects who test positive for isolated antibody to hepatitis B core antigen (anti-HBc) should be vaccinated with hepatitis B vaccine is not certain. Development of an anamnestic response after vaccination would suggest previous hepatitis B virus (HBV) infection, in which case vaccination is not necessary.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom